Pinnacle Life Science Private Limited - Due diligence report

A 360° intelligence report on Pinnacle Life Science: trust score, financial health, credit view, compliance, directors, growth and distress …

2003-01-15 Baddi, Himachal Pradesh Active Unlisted Active Compliant
Share
Connect MCP
PL Pinnacle Life Science Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Pinnacle Life Science — 360° Intelligence Report

Generated from MCA filings & public records
92/100
Trust Score
Low Risk

Pinnacle Life Science is assessed as Low Risk with a Trust Score of 92/100. Pinnacle Life Science is an active private limited indian non-government company incorporated in 2003, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 16 Aug 2026 from the latest processed filings. Pinnacle Life Science Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
92/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
86/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
75/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 75/100 Low Risk
  • Open charges exceed net worth - secured lenders rank ahead.
  • Moderate gearing (D/E 38%).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.
  • Externally credit-rated (A-).

Charges position: 13 open (386.56 cr) · 11 satisfied (58.24 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Axis Bank Limited4 48.0 cr
The Hongkong And Shanghai Banking Corporation Limited2 48.0 cr
Standard Chartered Bank5 48.0 cr
Others6 48.0 cr
The Saraswat Co-Operative Bank Ltd.3 48.0 cr
Uco Bank2 48.0 cr
Compliance Score: 86/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Litigation present in 2 court forum(s).
  • 7 active GST registration(s).
Legal cases on record (2)
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
HARSHIT MANILAL SAVLA 01234567 Director 01/04/2018 6 yrs Approved
HARIT PRAGJI SHAH 01234567 Director 01/04/2018 6 yrs Approved
NEHA RAJEN GADA 01234567 Director 01/04/2018 6 yrs Approved
PARTH SAMIR SHAH 01234567 Director 01/04/2018 6 yrs Approved
VISHWA HARSHIT SAVLA 01234567 Director 01/04/2018 6 yrs Approved
ADHISH PRAKASH PATIL 01234567 Director 01/04/2018 6 yrs Approved
RUSHIKESH VIVEK DEOLE 01234567 Director 01/04/2018 6 yrs Approved
  • 7 directors on the board.
  • No disqualified or deactivated DINs.
  • 1 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2024 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Aarti Drugs Limited
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Aarti Drugs Limited Holding Company 74.00%

Key managerial personnel: PARTH SAMIR SHAH (Whole-time director) · VISHWA HARSHIT SAVLA (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 95 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Profit expanded 2.1x year-on-year.
Asset base grew 24% - capacity expansion.
Net margin improved to 0.86.
EPFO headcount growing - hiring signal.
Operating for 23+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
13 open charge(s) registered - assets are encumbered.
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence89/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment84/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 13 open charge(s) of 386.56 cr already registered.
  • Compliance record supports lending.
Investor view94/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 5 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
23 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
06 Mar 2025
Charge created
The Hongkong And Shanghai Banking Corporation Limited - 40.00 cr
18 Sep 2024
Director ceased
NEHA RAJEN GADA
01 Jul 2024
Director appointed
NEHA RAJEN GADA (Director)
26 Oct 2023
Charge satisfied
Others
19 Jul 2023
Director appointed
PARTH SAMIR SHAH (Whole-time director)
Director ceased
PARTH SAMIR SHAH
19 May 2023
Charge created
Axis Bank Limited - 10.00 cr
03 Aug 2022
Director ceased
NAVIN CHAPSHI SHAH
29 Apr 2022
Charge created
Axis Bank Limited - 33.00 cr
31 Mar 2022
Director ceased
BHAVESH RASIKLAL VORA
Director ceased
RAJENDRA VALLABHAJI GOGRI
23 Mar 2022
Charge created
The Hongkong And Shanghai Banking Corporation Limited - 60.00 cr
04 Mar 2022
Charge created
Axis Bank Limited - 98.00 cr
10

Key Observations

Auto-generated from the data above
Revenue grew 61% over the last 4 financial year(s).
Net profit margin moved from 38% to 1.42.
Debt-to-equity stands at 2.1x - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
7 active director(s) / partner(s); board looks stable and experienced.
7 active GST registration(s) indicate ongoing business operations.
Carries an external credit rating of A- from Crisil.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2024 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Agrico Organics Limited U74899DL1995PLC067212 Delhi, Delhi, India
Organicindia U74130WB1997PTC280287 Kolkata, West Bengal, India
Parikh Enterprises Private Limited U51100GJ1966PTC001392 Ahmedabad, Gujarat, India
Ciron Drugs U24246MH1990PTC056735 Mumbai City, Maharashtra, India
Synergene Active Ingredients U24239TG2005PTC047137 Shaikpet, Telangana, India
Sheel Chand Agroils Private Limited U15142UP1994PTC016109 Nainital, Uttar Pradesh, India
Revex Plasticisers Private Limited U74899DL1981PTC011511 Delhi, Delhi, India
Kelvin Natural Mint Private Limited U36999UP2018PTC108645 Bareilly, Uttar Pradesh, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Pinnacle Life Science before audits and certifications: compliance score 86/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Pinnacle Life Science: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 75/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Pinnacle Life Science - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 92/100, distress signals and MSME payment-delay disclosures - know whether Pinnacle Life Science pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Pinnacle Life Science - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Pinnacle Life Science an active company?

Pinnacle Life Science has MCA status “Active” with a compliance score of 86/100 (Low Risk).

Is Pinnacle Life Science financially healthy?

Pinnacle Life Science has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.

Should I do business with Pinnacle Life Science?

Its overall Trust Score is 92/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Pinnacle Life Science?

The ultimate holding entity is Aarti Drugs Limited. 7 active director(s) are on record.

Does Pinnacle Life Science have loans or charges against its assets?

13 open charge(s) are registered against its assets, and 11 earlier charge(s) stand satisfied.

Is Pinnacle Life Science up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 86/100 (Low Risk).

Is it risky to lend to Pinnacle Life Science?

Its Credit Risk Score is 75/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.